ARCUTIS BIOTHERAPEUTICS INC shareholders Q2 2023

ARCUTIS BIOTHERAPEUTICS INC's ticker is ARQT and the CUSIP is 03969K108. A total of 140 filers reported holding ARCUTIS BIOTHERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 1.36 and the average weighting 0.1%.

ARCUTIS BIOTHERAPEUTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
Hennion & Walsh Asset Management, Inc. 102,413$9760.06%
Virtus ETF Advisers LLC 10,172$96,9390.06%
Tekla Capital Management LLC 148,874$1,418,7690.06%
Weiss Multi-Strategy Advisers LLC 268,947$2,5630.05%
PROFUND ADVISORS LLC 89,780$855,6030.05%
MARSHALL WACE, LLP 2,317,541$22,086,1660.04%
Quantamental Technologies LLC 10,304$98,1970.04%
Perceptive Advisors 300,000$1,417,5000.04%
JENNISON ASSOCIATES LLC 4,293,966$40,921,4950.03%
Rafferty Asset Management, LLC 499,922$4,764,2570.03%
SECTORAL ASSET MANAGEMENT INC 14,287$136,1550.02%
Caption Management, LLC 135,000$1,286,5500.02%
E Fund Management Co., Ltd. 26,877$2560.02%
Centiva Capital, LP 90,000$857,7000.02%
Virtu Financial LLC 21,769$2070.02%
Ensign Peak Advisors, Inc 832,540$7,934,1060.02%
PICTET ASSET MANAGEMENT SA 1,327,029$12,646,5860.02%
AXA S.A. 448,642$4,275,5580.01%
Caption Management, LLC 85,000$810,0500.01%
CANTOR FITZGERALD, L. P. 56,903$542,2860.01%
External links

This page lists ARCUTIS BIOTHERAPEUTICS INC's shareholders in Q2 2023. To view ARCUTIS BIOTHERAPEUTICS INC's shareholder history, click here.